Søren Erik Pedersen

Søren Erik Pedersen's AcademicInfluence.com Rankings

Søren Erik Pedersen

Philosophy

#8118

World Rank

#11441

Historical Rank

Logic

#5151

World Rank

#6526

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Søren Erik Pedersen's Degrees

PhD Medical Science University of Copenhagen
Doctorate Medicine University of Copenhagen

Why Is Søren Erik Pedersen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Søren Erik Pedersen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global strategy for asthma management and prevention: GINA executive summary (2008) (2982)
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. (2004) (1335)
Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. (1994) (750)
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial (2003) (698)
A summary of the new GINA strategy: a roadmap to asthma control (2015) (685)
Efficacy and Safety of Inhaled Corticosteroids in Asthma (1993) (487)
Asthma (2018) (406)
Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. (2000) (397)
Severe exacerbations and decline in lung function in asthma. (2009) (371)
A comparison of the efficacy and safety of inhaled corticosteroids in asthma (1997) (363)
Early identification of atopy in the prediction of persistent asthma in children (2008) (325)
Management of asthma: a consensus statement. (1989) (260)
Influence of inspiratory flow rate upon the effect of a Turbuhaler. (1990) (248)
GINA 2019: a fundamental change in asthma management (2019) (244)
Budesonide treatment of moderate and severe asthma in children: a dose-response study. (1995) (241)
Growth of asthmatic children during treatment with budesonide: a double blind trial. (1991) (222)
Errors in Inhalation Technique and Efficiency in Inhaler Use in Asthmatic Children (1986) (212)
Classification and pharmacological treatment of preschool wheezing: changes since 2008 (2014) (181)
Importance of the inhalation device on the effect of budesonide. (1993) (166)
Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. (1992) (160)
The correlation between asthma control and health status: the GOAL study (2006) (160)
Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. (2003) (158)
Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. (1998) (148)
The Global Initiative for Asthma (GINA): 25 years later (2019) (146)
Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study (2017) (140)
Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. (1993) (126)
Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. (1993) (125)
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. (1997) (121)
Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. (1997) (115)
Short term linear growth in asthmatic children during treatment with prednisolone. (1990) (113)
Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. (2016) (112)
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. (2006) (112)
Short‐term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids (1993) (110)
Canadian Pediatric Asthma Consensus Guidelines, 2003 (updated to December 2004): Introduction (2005) (108)
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care (2012) (107)
Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. (1993) (106)
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study (2008) (104)
Risks of pneumonia in patients with asthma taking inhaled corticosteroids. (2011) (104)
Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. (2008) (100)
Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
Effect of asthma treatment on fitness, daily activity and body composition in children with asthma (2010) (94)
Fitness, daily activity and body composition in children with newly diagnosed, untreated asthma (2009) (91)
The poorly explored impact of uncontrolled asthma. (2013) (91)
Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. (1988) (91)
Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. (2006) (89)
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
Cost‐effectiveness of asthma control: an economic appraisal of the GOAL study (2006) (86)
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. (2007) (84)
Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. (1992) (82)
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
Knemometric assessment of systemic activity of once daily intranasal dry‐powder budesonide in children (1994) (80)
How to use a rotahaler. (1986) (79)
Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. (1999) (77)
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. (2008) (76)
Measuring efficacy and safety of different inhaled corticosteroid preparations. (1998) (75)
Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. (1998) (75)
Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. (2002) (73)
Systemic availability and pharmacokinetics of nebulised budesonide in preschool children (1999) (72)
Clinical Safety of Inhaled Corticosteroids for Asthma in Children (2006) (72)
Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. (1986) (70)
Aerosol treatment of bronchoconstriction in children, with or without a tube spacer. (1983) (70)
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal (2010) (70)
Erratic absorption of a slow-release theophylline sprinkle product. (1984) (69)
Inhalers and nebulizers: which to choose and why. (1996) (68)
Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. (2005) (63)
Canadian Pediatric Asthma Consensus guidelines (2005) (58)
Influence of spacer device on drug delivery to young children with asthma. (1994) (56)
The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. (2009) (55)
The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. (1993) (55)
Importance of training for correct Turbuhaler use in preschool children (1998) (53)
Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. (2003) (53)
Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food. (1981) (52)
Effect of salmeterol treatment on nitric oxide level in exhaled air and dose–response to terbutaline in children with mild asthma (1998) (51)
The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma. (2010) (51)
Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children (2003) (49)
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
Influence of Food on the Absorption Rate and Bioavailability of a Sustained Release Theophylline Preparation (1982) (48)
Early use oe inhaled steroids in children with asthma (1997) (44)
Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide. (2005) (43)
Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma (2004) (42)
Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial (2006) (42)
Dose-response relationships of intravenously administered terbutaline in children with asthma. (1989) (41)
Optimal inhalation technique with terbutaline Turbuhaler. (1989) (40)
From asthma severity to control: a shift in clinical practice. (2009) (40)
Improving the global diagnosis and management of asthma in children (2018) (39)
Efficacy and safety of salmeterol in childhood asthma (1995) (38)
Fenoterol powder inhaler technique in children: influence of inspiratory flow rate and breath-holding. (1986) (38)
The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design. (2001) (37)
Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study. (2010) (36)
Pharmacokinetics of budesonide in children with asthma (2004) (36)
Rate of Response of Individual Asthma Control Measures Varies and May Overestimate Asthma Control: An Analysis of the Goal Study (2007) (35)
Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma. (1999) (35)
Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. (2009) (34)
Inhaler use in children with asthma. (1987) (34)
Breath-Synchronized Nebulization Diminishes the Impact of Patient-Device Interfaces (Face Mask or Mouthpiece) on the Inhaled Mass of Nebulized Budesonide (2000) (33)
Comparison of a new multidose powder inhaler with a pressurized aerosol in children with asthma (1989) (33)
Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. (1995) (32)
Assessing the effect of intranasal steroids on growth. (2001) (31)
Use of budesonide Turbuhaler in young children suspected of asthma. (1994) (31)
Safety of treatment. (1996) (31)
Lower‐leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate (2010) (31)
Placebo‐controlled study of montelukast and budesonide on short‐term growth in prepubertal asthmatic children (2007) (30)
Country-specific cost-effectiveness of early intervention with budesonide in mild asthma (2004) (30)
Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial. (2002) (29)
Adrenal Function in Asthmatic Children Treated with Inhaled Budesonide (1991) (28)
Preschool asthma--not so easy to diagnose. (2007) (27)
Food induced changes in theophylline absorption from a once-a-day theophylline product. (1986) (27)
Knemometry in the assessment of short-term linear growth in a population of healthy school children. (1992) (26)
Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis. (2014) (26)
Nasal Inhalation as a Cause of Inefficient Pulmonal Aerosol Inhalation Technique in Children (1983) (25)
Treatment of Acute Bronchoconstriction in Children with Use of a Tube Spacer Aerosol and a Dry Powder Inhaler (1985) (23)
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. (2008) (22)
Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. (2011) (22)
Optimal use of tube spacer aerosols in asthmatic children (1985) (21)
How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze (2015) (20)
A double‐blind, placebo‐controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitis (1992) (20)
A worldwide charter for all children with asthma (2020) (20)
Influence of budesonide on the response to inhaled terbutaline in children with mild asthma (1995) (19)
Treatment of nocturnal asthma in children with a single dose of sustained‐release theophylline taken after supper (1985) (19)
Nebulized Inhaled Corticosteroids in Asthma Treatment in Children ≤5 Years of Age: A Systematic Review and Global Expert Analysis. (2020) (18)
Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma. (1987) (17)
Inspiratory capacity through the Turbuhaler in various patient groups. (1994) (17)
Effects of food on the absorption of theophylline in children. (1986) (16)
A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. (2006) (16)
Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents. (1993) (16)
Asthma control in children: Is it important and can we measure it? (2016) (16)
Why does airway inflammation persist? Is it failure to treat early? (2000) (15)
Influence of food on the absorption of theophylline from a sustained release formulation (Somophyllin ® ) (1985) (15)
The role of inhaled corticosteroids in management of asthma in infants and preschoolers (2013) (14)
Exhaled nitric oxide in guideline-based asthma management (2008) (14)
[Peroral drug administration to children--are there any problems?]. (1998) (14)
Long‐term outcomes in paediatric asthma (2002) (12)
The importance of a pause between the inhalation of two puffs of terbutaline from a pressurized aerosol with a tube spacer. (1986) (11)
Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline. (2004) (11)
Pharmacological interventions. Childhood asthma. (1998) (10)
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
Use of different inhalation devices in children (2007) (10)
The Role of Aeroallergen Sensitization Testing in Asthma Management. (2020) (8)
Cathodic trypsin-like immunoreactivity in serum: influence of sex, age, renal function, food and diurnal variation. (1982) (8)
Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks? (2008) (8)
Asthma: moving toward a global children's charter. (2019) (8)
Delivery options for inhaled therapy in children over the age of 6 years. (1997) (8)
A review of the burden and management of mild asthma in adults - Implications for clinical practice. (2019) (8)
Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3‐year results of the START study (2006) (8)
Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma. (2016) (7)
Absorption of Theo-Dur Sprinkle with food: importance of types of meals and medication times. (1986) (7)
INAPPROPRIATE STATISTICS. AUTHOR'S REPLIES (1993) (7)
GINA EXECUTIVE COMMITTEE (2006) (7)
Comparing inhaled glucocorticosteroids (1999) (7)
Components of asthma control and treatment response of individual control criteria in children: Analysis of the PEACE study (2011) (7)
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy (2016) (7)
Lower-leg growth in children with asthma during treatment with inhaled corticosteroids* (2003) (6)
Serum Concentrations of Theophylline in Children Treated with Two Daily Doses of a Sustained‐Release Theophylline Preparation (1981) (6)
Cumulative dose response relationship of terbutaline delivered by three different inhalers (1988) (6)
Role of budesonide as maintenance therapy for children with asthma (2003) (6)
Salmeterol/fluticasone and fluticasone alone are well tolerated over 1 year of treatment stepped-up to achieve total control: Safety results of the GOAL study (2004) (6)
Can total control of asthma be achieved? The results of the GOAL study☆ (2004) (6)
Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations. (2012) (6)
Achieving GINA/NIH guideline-based asthma control with salmeterol/fluticasone compared with fluticasone alone: The results of the GOAL study☆ (2004) (6)
Lower-leg growth rate and HPA-axis function in children with asthma during treatment with inhaled ciclesonide (2004) (6)
Simplification of Inhalation Therapy in Asthmatic children (1986) (6)
Improvements in asthma outcomes following 1 year of treatment with salmeterol/fluticasone or fluticasone alone when stepped up to achieve guideline-defined total control (2004) (5)
Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children. (1994) (5)
The effect of oral corticosteroids and high-dose combination therapy on achieving control of refractory asthma (2004) (5)
Improved exacerbation rates and asthma control in current and former smokers treated with salmeterol/fluticasone propionate: Results of the GOAL study (2005) (5)
ABSORPTION AND SUSTAINED RELEASE THEOPHYLLINE (1983) (5)
GINA 2016-derived asthma control with fluticasone propionate/salmeterol: a Gaining Optimal Asthma controL (GOAL) study reanalysis. (2019) (5)
Food and Fasting Absorption of a Single Dose of a Sustained Release Theophylline Sprinkle Formulation in Children (1986) (5)
Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol (2019) (5)
[Budesonide administered via Turbuhaler and a nebulator]. (1994) (4)
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
Food and fasting intake of sustained release theophylline preparations. (1984) (4)
Ciclesonide is effective in protecting against exercise-induced bronchoconstriction (2005) (4)
[Effect of long-term treatment with inhaled budesonide on adult height of children with asthma]. (2001) (3)
[Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial]. (1994) (3)
Measuring childhood asthma control. (2014) (3)
Effect Of Inhaled Budesonide Treatment For A Mean Of 14 Years On Peak Bone Mineral Density In Children With Asthma (2010) (3)
Comparative study designs and what they show. (2000) (3)
Comparison of oestradiol and prostaglandin E2 vaginal gel for ripening the unfavourable cervix (1981) (3)
Long-term treatment of children with sustained-release theophylline. (1983) (3)
[The effect of induction of labor with endocervical balloon catheter with or without estradiol therapy]. (1981) (3)
[A fatal case after explosion during cyclopropane anesthesia]. (1979) (2)
IMPROVED ASTHMA CONTROL AND FEWER EXACERBATIONS WITH INHALED SALMETEROL/FLUTICASONE PROPIONATE COMPARED WITH ORAL MONTELUKAST IN CHILDREN WITH PERSISTENT ASTHMA: PEACE (PEDIATRIC ASTHMA CONTROL EVALUATION) (2008) (2)
Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day (2017) (2)
Systemic availability (Lung deposition) of drug from two different dry-powder inhalers in children with asthma (2003) (2)
SAFETY AND EFFICACY OF INHALED CORTICOSTEROIDS IN CHILDREN (1999) (2)
Treatment of children with a single dose a day of sustained release theophylline. (1982) (2)
[Childhood asthma: Danish guidelines for diagnosis and treatment]. (2013) (2)
[Neisseria cinerea infection in a neonate. Suspected gonococcal infection]. (1985) (2)
Nebulizers in childhood (2000) (2)
Factors influencing physical fitness and body per cent fat in asthmatic children and healthy controls (2008) (1)
Clinical issues in paediatric asthma. (1997) (1)
Early Pharmacologic Intervention of Asthma: How Early and What Treatment? (2005) (1)
Early pharmacological intervention in mild pediatric asthma – background and definitions (2006) (1)
RESPONSE TO J. O. WARNER (1997) (1)
The airway epithelium in childhood asthma. (2012) (1)
Treatment For A Mean Of 16 Years With Inhaled Budesonide In Children With Asthma: Effect On Intraocular Pressure And Occurrence Of Cataracts (2011) (1)
Effect of inhaled therapeutic interventions on the natural history of asthma (1998) (1)
LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma (2016) (1)
Inhaled corticosteroids and growth: How big a dose of caution? (2002) (1)
Effects of inhaled corticosteroids on linear growth in children with asthma. (1994) (1)
Asthma begins in childhood (1999) (1)
Early intervention with budesonide in recent onset mild persistent asthma in children: START trial results (2005) (1)
What Is the Right Dose of Systemic Corticosteroids for Intensive Care Unit Patients with Chronic Obstructive Pulmonary Disease Exacerbations (2014) (0)
[A rapid method for theophylline determination in whole blood]. (1987) (0)
Safety and Tolerability of Inhaled Ciclesonide in Children Aged 6-11 Years with Asthma: The Rainbow Study. (2009) (0)
Long-term safety of extrafine and conventional beclomethasone dipropionate aerosols in pediatric asthma (2002) (0)
Authors' response (2010) (0)
Treatment of Asthma in Children: the Case for Inhaled Corticosteroids as First Line Agents (2000) (0)
Efficacy and Safety of Ciclesonide MDI for the Treatment of Asthma in Children Aged 6-11 Years – Impact of Spacer Use. (2009) (0)
[Double-blind randomized trial of the effect of Bidro on hay fever in children]. (2005) (0)
[No risk of development of osteoporosis or inhibition of growth in children with asthma treated with inhaled corticosteroids]. (2005) (0)
Low-dose budesonide treatment reduces severe asthma-related events in patients with infrequent asthma symptoms at baseline: A post-hoc analysis of the start study (2015) (0)
Early identification of children likely to develop persistent asthma : atopy is an integral component of the high risk phenotype (2015) (0)
Low-dose budesonide treatment improves lung function in patients with infrequent asthma symptoms at baseline: A post-hoc analysis of the start study (2015) (0)
Safety and tolerability of inhaled budesonide in children in the START trial (2005) (0)
Pediatric asthma treatment up to date (2005) (0)
Pediatric pulmonology workshop Jerusalem, Israel, March 30‐April 2, 1987 (1988) (0)
Paradigm shift in asthma management - towards a control centric areas: The new GINA guidelines (2008) (0)
A pressurized beta 2-agonist aerosol used in the treatment of children with asthma caused by bronchial provocation. (1982) (0)
Once nightly sustained release theophylline in elderly subjects ― a reply (1988) (0)
Rectal administration of theophylline in aqueous solution. (1981) (0)
[Reply: Allergy is not always the cause of asthma]. (2013) (0)
Pharmacokinetics of a new theophylline liquid in asthmatic children. (1983) (0)
Foreword (1999) (0)
Reply (2012) (0)
Efficacy of beclomethasone dipropionate (BDP) extrafine aerosol following switch from conventional BDP in children with asthma (2002) (0)
[Steroid treatment of asthmatic children]. (1997) (0)
[Reye's syndrome and adenovirus pneumonia with extrapulmonary manifestations. A comparison]. (1985) (0)
Allan Becker; Denis Bérubé; Zave Chad; Myrna Dolovich; Francine Ducharme; Tony D'Urzo; (2005) (0)
Fitness, physical activity and per cent body fat in asthmatic children and healthy controls (2008) (0)
[Guidelines for treatment of bronchial asthma in children. Dansk Paediatrisk Selkabs Astma- og Allergiudvalg]. (1997) (0)
Childhood Asthma Management in the Next 10 Years (2005) (0)
No dose effect observed with chronic fluticasone propionate on growth velocity in children (2020) (0)
Efficacy of Inhaled Ciclesonide in Children Aged 6-11 Years with Asthma: The Rainbow Study. (2009) (0)
46 – Asthma in Children (1998) (0)
Time of Achievement of Final Adult Height in Children Treated with Inhaled Budesonide (2006) (0)
Treatment of acute asthma in children with rectal administration of aminophylline solution. (1984) (0)
Long-term safety of inhaled corticosteroids in children (2010) (0)
The outcome of pregnancy in a randomized controlled study including women with asthma exposed to budesonide. (2005) (0)
[Pediatric pulmonology]. (2001) (0)
[Inhaled steroids and growth inhibition]. (1990) (0)
Corrigendum to "A review of the burden and management of mild asthma in adults - Implications for clinical practice" [Respir. Med. 152 (2019) 97-104]. (2020) (0)
Asthma control – components and clinical importance (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Søren Erik Pedersen?

Søren Erik Pedersen is affiliated with the following schools:

University of Southern Denmark